DANIELLE LECLAIR: Open Payments
NPI 1225121098 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 9 payments from 8 companies in 2025. Trend: 2023 $513 · 2024 $802 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $234 |
| ABBVIE INC. | 1 | $125 |
| Alkermes, Inc. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| GENZYME CORPORATION | 1 | $119 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Insmed, Inc. | 1 | $93 |
| Sage Therapeutics, LLC | 1 | $77 |
Products named: SKYRIZI, LYBALVI, DUPIXENT, Auvelity, Rhapsido, Arikayce.
Industry payments across MD — which companies pay providers there.
